[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Ophthalmic Therapeutics/Drugs Market to Reach USD 35.7 Bn by 2025, Expects Grand View Research in Its Study Available at MarketPublishers.com

01 Dec 2017 • by Natalie Aster

LONDON – Globally, the ophthalmic therapeutics/drugs market is poised to follow an upward trend to climb to a value of USD 35.7 billion by 2025. Some of the factors fuelling the sector’s growth include an upsurge in funding by private and public institutions for carrying out research on ocular diseases with the existence of strong emerging drugs in the pipeline.

Manifold ongoing public-private partnerships in the pharma domain for the development of new therapeutics are projected to open up lucrative growth opportunities in the market. Over the past few years, there have emerged a range of safe, highly-effective agents to treat fungal eye diseases. Natamycin, clotrimazole, amphotericin B are amid the most high-potential therapeutics available in the marketplace.

With respect to the class of drugs, the antiallergy segment is the leader due to the surging incidence rate of eye infections, high prescription rate of anti-allergy agents, and the availability of a vast product portfolio.

By disease type, retinal disorders led the market as of 2016 owing to the rising prevalence rates of age-related macular degenerations (AMDs) and diabetic retinitis, its subtypes.

North America took the lead in the market in 2016 on the back of such factors as the increased demand for ophthalmic solutions to treat glaucoma and dry eyes in the region.

APAC is poised to see the most rapid growth at a lucrative CAGR in the offing owing to the surging disposable income levels, a huge population base, and expanding awareness programmes by different organisations.

In-demand research report “Ophthalmic Therapeutics/Drug Market Analysis By Class, By Disease, And Segment Forecasts, 2014 - 2025” drawn up by Grand View Research offers a profound, unbiased analysis of the situation in the market worldwide.

The research study market segmentation based on drug class, disease type, dosage form, product, and by region; it provides market size estimates and trends for each of the segments. The report presents an all-round assessment of the market drivers and restraints, provides an overview of market penetration, provides a detailed SWOT analysis by factor, includes granular Porter’s five forces analysis, and speculates on the growth prospects of the marketplace. The report canvasses the competitive scenario and provides granular profiles of the 12 leading market participants.

More in-demand reports by Grand View Research are available in the publisher's online catalogue.


The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected]

Analytics & News

Weekly Digest